BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37389802)

  • 1. Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC).
    Jovanoski N; Abogunrin S; Di Maio D; Belleli R; Hudson P; Bhadti S; Jones LG
    Pharmacoeconomics; 2023 Nov; 41(11):1437-1452. PubMed ID: 37389802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health State Utility Values in Early-Stage Non-small Cell Lung Cancer: A Systematic Literature Review.
    Jovanoski N; Abogunrin S; Di Maio D; Belleli R; Hudson P; Bhadti S; Jones LG
    Pharmacoecon Open; 2023 Sep; 7(5):723-738. PubMed ID: 37289325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
    Andreas S; Chouaid C; Danson S; Siakpere O; Benjamin L; Ehness R; Dramard-Goasdoue MH; Barth J; Hoffmann H; Potter V; Barlesi F; Chirila C; Hollis K; Sweeney C; Price M; Wolowacz S; Kaye JA; Kontoudis I
    Lung Cancer; 2018 Oct; 124():298-309. PubMed ID: 29961557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review.
    Franklin M; Pollard D; Sah J; Rayner A; Sun Y; Dube F; Sutton A; Qin L
    Adv Ther; 2024 Jul; 41(7):2700-2722. PubMed ID: 38833143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Literature Review to Assess the Cost and Resource Use Associated with Spinal Muscular Atrophy Management.
    Paracha N; Hudson P; Mitchell S; Sutherland CS
    Pharmacoeconomics; 2022 Apr; 40(Suppl 1):11-38. PubMed ID: 34761360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA).
    Paracha N; Hudson P; Mitchell S; Sutherland CS
    Pharmacoeconomics; 2022 Apr; 40(Suppl 1):69-89. PubMed ID: 34658008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC).
    Chayab L; Konstantelos N; Leighl NB; Tadrous M; Wong WWL
    Pharmacoeconomics; 2023 Aug; 41(8):945-980. PubMed ID: 37268866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain.
    De Castro J; Insa A; Collado-Borrell R; Escudero-Vilaplana V; Martínez A; Fernandez E; Sullivan I; Arrabal N; Carcedo D; Manzaneque A
    BMC Pulm Med; 2023 Feb; 23(1):69. PubMed ID: 36809990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic burden of schizophrenia: a targeted literature review of types of costs and associated drivers across 10 countries.
    Kotzeva A; Mittal D; Desai S; Judge D; Samanta K
    J Med Econ; 2023; 26(1):70-83. PubMed ID: 36503357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study.
    Lee DH; Isobe H; Wirtz H; Aleixo SB; Parente P; de Marinis F; Huang M; Arunachalam A; Kothari S; Cao X; Donnini N; Woodgate AM; de Castro J
    BMC Health Serv Res; 2018 Mar; 18(1):147. PubMed ID: 29490654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Literature Review to Identify Utility Values in Patients with Spinal Muscular Atrophy (SMA) and Their Caregivers.
    Sutherland CS; Hudson P; Mitchell S; Paracha N
    Pharmacoeconomics; 2022 Apr; 40(Suppl 1):39-67. PubMed ID: 34907515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-country review of data collected on non-small cell lung cancer (NSCLC) patients in cancer registries, databases, retrospective and non-randomized prospective studies.
    De Geer A; Eriksson J; Finnern HW
    J Med Econ; 2013; 16(1):134-49. PubMed ID: 22702446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage.
    Wood R; Taylor-Stokes G
    BMC Cancer; 2019 Mar; 19(1):214. PubMed ID: 30849964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of economic evaluations in second and later lines of therapy for the treatment of non-small cell lung cancer.
    Jäkel A; Plested M; Dharamshi K; Modha R; Bridge S; Johns A
    Appl Health Econ Health Policy; 2013 Feb; 11(1):27-43. PubMed ID: 23329379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Burden of Recurrence in Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer: A Retrospective Study Using Nationwide Claims Data of South Korea.
    Byun JY; Lee JE; Shim YB; Kim J; Lee SY; Shin BR; Yoon NR; Park MH; Lee EK
    Adv Ther; 2023 Feb; 40(2):550-567. PubMed ID: 36404368
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.